From the Patersons report re HSV...
"After 12 weeks from the initial inoculation, study arm patients went from a 38% reduction in viral shedding to a 58% reduction over an additional 9 months and after 2 boosters. If that trend was to continue over an additional year (= 2 additional 6 month boosters), the viral shedding rate would fall another 20% to 78%. At this level of reduction, COR-1 would be able to usurp the long-term antiviral market. And if the trend indicated with this curve was to continue over two years (=4 additional boosters), COR-1 would get to the status of a practical cure for HSV-2, with a reduction in viral shedding of 98%".
I think anything over 65%% reduction in this months announcement and it really is game on.
GLTAH
From the Patersons report re HSV... "After 12 weeks from the...
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.76 |
Change
-0.390(3.21%) |
Mkt cap ! $248.6M | |||
| Open | High | Low | Value | Volume |
| $12.15 | $12.27 | $11.27 | $382.7K | 32.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 420 | $11.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.85 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |